Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone516-665-8200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$7.72 million
Profitability
Miscellaneous
Employees18
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
BeyondAirInc . (NASDAQ:XAIR) Frequently Asked Questions
What is BeyondAirInc .'s stock symbol?
BeyondAirInc . trades on the NASDAQ under the ticker symbol "XAIR."
How were BeyondAirInc .'s earnings last quarter?
BeyondAirInc . (NASDAQ:XAIR) announced its quarterly earnings data on Tuesday, June, 25th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by $0.13. The business earned $7.70 million during the quarter, compared to analysts' expectations of $2.75 million. View BeyondAirInc .'s Earnings History.
When is BeyondAirInc .'s next earnings date?
Has BeyondAirInc . been receiving favorable news coverage?
Media coverage about XAIR stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. BeyondAirInc . earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for BeyondAirInc ..
Who are some of BeyondAirInc .'s key competitors?
Some companies that are related to BeyondAirInc . include Neuronetics (STIM), Cytosorbents (CTSO), Vapotherm (VAPO), Repro-Med Systems (REPR), iCAD (ICAD), RenovaCare (RCAR), T2 Biosystems (TTOO), BRAINSWAY LTD/S (BWAY), Sensus Healthcare (SRTS), Motus GI (MOTS), Liquidia Technologies (LQDA), Apollo Endosurgery (APEN), Spectral Medical (EDTXF), Endologix (ELGX) and STRATA Skin Sciences (SSKN).
Who are BeyondAirInc .'s key executives?
BeyondAirInc .'s management team includes the folowing people:
- Mr. Steven Adam Lisi, CEO & Chairman (Age 48)
- Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 45)
- Mr. Douglas J. Beck CPA, Chief Financial Officer (Age 58)
- Mr. Adam Newman, Chief Legal Officer & Gen. Counsel
- Mr. Duncan Fatkin, Chief Commercial Officer
How do I buy shares of BeyondAirInc .?
Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is BeyondAirInc .'s stock price today?
One share of XAIR stock can currently be purchased for approximately $4.93.
How big of a company is BeyondAirInc .?
BeyondAirInc . has a market capitalization of $52.95 million and generates $7.72 million in revenue each year. The company earns $-6,560,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. BeyondAirInc . employs 18 workers across the globe.View Additional Information About BeyondAirInc ..
What is BeyondAirInc .'s official website?
How can I contact BeyondAirInc .?
BeyondAirInc .'s mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at 516-665-8200.
MarketBeat Community Rating for BeyondAirInc . (NASDAQ XAIR)
MarketBeat's community ratings are surveys of what our community members think about BeyondAirInc . and other stocks. Vote "Outperform" if you believe XAIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XAIR will underperform the S&P 500 over the long term. You may vote once every thirty days.
